VETINUITY
What is the current FDA drug shortage status of lidocaine?
FDA lists lidocaine hydrochloride injection in shortage on the human drug shortage database, with availability varying by specific manufacturer and package presentation.
● ANSWER
Sourced & dated
Lidocaine FDA Drug Shortage Status
FDA shortage status by lidocaine injection presentation, plus lidocaine and bupivacaine onset and duration for local blocks in dogs and cats.
● WHAT'S DOCUMENTED
FDA lists human-labeled lidocaine hydrochloride injection in shortage, with specific package presentations designated as Available, Limited Availability, or Unavailable.
Lidocaine: human-labeled FDA records matched to our veterinary drug catalog.
Lidocaine FDA product records
| FDA field | Product-specific value |
|---|---|
| Record 1 | Lidocaine Hydrochloride Injection |
| FDA generic name | Lidocaine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-159-74) |
| Company | Eugia US LLC |
| First posted | 02/20/2018 |
| FDA updated | 10/19/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Unavailable |
| FDA additional information | On backorder. Recovery: TBD. Check wholesalers for inventory |
| Package NDC | 55150-159-74 |
| Record 2 | Lidocaine Hydrochloride Injection |
| FDA generic name | Lidocaine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-57) |
| Company | Fresenius Kabi USA, LLC |
| First posted | 02/22/2012 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia, Pediatric |
| Presentation availability | Available |
| FDA additional information | Check wholesalers for inventory |
| Package NDC | 63323-492-57 |
| Record 3 | Lidocaine Hydrochloride Injection |
| FDA generic name | Lidocaine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Xylocaine, Injection, 20 mg/1 mL (NDC 63323-496-97) |
| Company | Fresenius Kabi USA, LLC |
| First posted | 02/22/2012 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia, Pediatric |
| Presentation availability | Unavailable |
| FDA additional information | Estimated recovery: TBD |
| Package NDC | 63323-496-97 |
| Record 4 | Lidocaine Hydrochloride Injection |
| FDA generic name | Lidocaine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-254-10) |
| Company | Eugia US LLC |
| First posted | 06/13/2018 |
| FDA updated | 10/19/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Unavailable |
| FDA additional information | On backorder. Recovery: late-November 2026; Check wholesalers for inventory |
| Package NDC | 55150-254-10 |
| Record 5 | Lidocaine Hydrochloride Injection |
| FDA generic name | Lidocaine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 0143-9577-10) |
| Company | Hikma Pharmaceuticals USA, Inc. |
| First posted | 06/13/2018 |
| FDA updated | 10/14/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Available |
| FDA additional information | Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released. |
| Package NDC | 0143-9577-10 |
| Record 6 | Lidocaine Hydrochloride Injection |
| FDA generic name | Lidocaine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-31) |
| Company | Fresenius Kabi USA, LLC |
| First posted | 02/22/2012 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia, Pediatric |
| Presentation availability | Unavailable |
| FDA additional information | Estimated recovery: TBD |
| Package NDC | 63323-492-31 |
| Record 7 | Lidocaine Hydrochloride Injection |
| FDA generic name | Lidocaine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-37) |
| Company | Fresenius Kabi USA, LLC |
| First posted | 02/22/2012 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia, Pediatric |
| Presentation availability | Available |
| FDA additional information | Check wholesalers for inventory |
| Package NDC | 63323-492-37 |
| Record 8 | Lidocaine Hydrochloride Injection |
| FDA generic name | Lidocaine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Lidocaine Hydrochloride And Dextrose, Injection, 5 g/100 mL; .4 g/100 mL (NDC 0264-9594-20) |
| Company | B. Braun Medical Inc. |
| First posted | 10/25/2017 |
| FDA updated | 11/10/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Cardiovascular |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 0264-9594-20 |
| Record 9 | Lidocaine Hydrochloride Injection |
| FDA generic name | Lidocaine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-164-02) |
| Company | Eugia US LLC |
| First posted | 02/20/2018 |
| FDA updated | 10/19/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Available |
| FDA additional information | Check wholesalers for inventory |
| Package NDC | 55150-164-02 |
| Record 10 | Lidocaine Hydrochloride Injection |
| FDA generic name | Lidocaine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Xylocaine, Injection, 10 mg/1 mL (NDC 63323-485-27) |
| Company | Fresenius Kabi USA, LLC |
| First posted | 02/22/2012 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia, Pediatric |
| Presentation availability | Available |
| FDA additional information | Check wholesalers for inventory |
| Package NDC | 63323-485-27 |
| Record 11 | Lidocaine Hydrochloride Injection |
| FDA generic name | Lidocaine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Lidocaine Hydrochloride In Plastic Container, Injection, 250 mg/50 mL (0.5%; 5 mg/mL) (NDC 0409-4275-01) |
| Company | Hospira, Inc., a Pfizer Company |
| First posted | 02/22/2012 |
| FDA updated | 11/09/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia, Pediatric |
| Presentation availability | Unavailable |
| FDA additional information | Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay |
| Package NDC | 0409-4275-01 |
| Record 12 | Lidocaine Hydrochloride Injection |
| FDA generic name | Lidocaine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Lidocaine Hydrochloride, Injection, 20 mg/2 mL (NDC 83634-653-02) |
| Company | Anthea Pharma |
| First posted | 02/22/2012 |
| FDA updated | 11/02/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia, Pediatric |
| Presentation availability | Available |
| FDA additional information | Distributed by Avenacy, LLC |
| Package NDC | 83634-653-02 |
| Record 13 | Lidocaine Hydrochloride Injection |
| FDA generic name | Lidocaine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Lidocaine Hydrochloride Preservative Free In Plastic Container, Injection, 50 mg/5mL (1%, 10 mg/1 mL) Syringes (NDC 0409-9137-05) |
| Company | Hospira, Inc., a Pfizer Company |
| First posted | 02/22/2012 |
| FDA updated | 11/09/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia, Pediatric |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 0409-9137-05 |
| Record 14 | Lidocaine Hydrochloride Injection |
| FDA generic name | Lidocaine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Lidocaine Hydrochloride Preservative Free, Injection, 200 mg/5 mL (4%; 40 mg/mL) (NDC 0409-4283-01) |
| Company | Hospira, Inc., a Pfizer Company |
| First posted | 02/22/2012 |
| FDA updated | 11/09/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia, Pediatric |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 0409-4283-01 |
| Record 15 | Lidocaine Hydrochloride Injection |
| FDA generic name | Lidocaine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 0143-9575-10) |
| Company | Hikma Pharmaceuticals USA, Inc. |
| First posted | 06/13/2018 |
| FDA updated | 10/14/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Available |
| FDA additional information | Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released. |
| Package NDC | 0143-9575-10 |
| Record 16 | Lidocaine Hydrochloride Injection |
| FDA generic name | Lidocaine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-161-02) |
| Company | Eugia US LLC |
| First posted | 02/20/2018 |
| FDA updated | 10/19/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Available |
| FDA additional information | Check wholesalers for inventory |
| Package NDC | 55150-161-02 |
| Record 17 | Lidocaine Hydrochloride Injection |
| FDA generic name | Lidocaine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-255-20) |
| Company | Eugia US LLC |
| First posted | 06/13/2018 |
| FDA updated | 10/19/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Available |
| FDA additional information | Check wholesalers for inventory |
| Package NDC | 55150-255-20 |
| Record 18 | Lidocaine Hydrochloride Injection |
| FDA generic name | Lidocaine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Lidocaine Hydochloride, Injection, 50 mg/5 mL (NDC 83634-653-05) |
| Company | Anthea Pharma |
| First posted | 02/22/2012 |
| FDA updated | 11/02/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia, Pediatric |
| Presentation availability | Available |
| FDA additional information | Distributed by Avenacy, LLC |
| Package NDC | 83634-653-05 |
| Record 19 | Lidocaine Hydrochloride Injection |
| FDA generic name | Lidocaine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Lidocaine Hydrochloride, Injection, 40 mg/2 mL (2%; 20 mg/mL) (NDC 0409-4282-01) |
| Company | Hospira, Inc., a Pfizer Company |
| First posted | 02/22/2012 |
| FDA updated | 11/09/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia, Pediatric |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 0409-4282-01 |
| Record 20 | Lidocaine Hydrochloride Injection |
| FDA generic name | Lidocaine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Lidocaine Hydrochloride, Injection, 10 mg/mL (NDC 55150-251-10) |
| Company | Eugia US LLC |
| First posted | 06/13/2018 |
| FDA updated | 10/19/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Available |
| FDA additional information | Check wholesalers for inventory |
| Package NDC | 55150-251-10 |
| Record 21 | Lidocaine Hydrochloride Injection |
| FDA generic name | Lidocaine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Lidocaine Hydrochloride And Dextrose, Injection, 4 mg/1 mL (NDC 0338-0409-03) |
| Company | Baxter Healthcare |
| First posted | 10/25/2017 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Cardiovascular |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 0338-0409-03 |
| Record 22 | Lidocaine Hydrochloride Injection |
| FDA generic name | Lidocaine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-256-50) |
| Company | Eugia US LLC |
| First posted | 06/13/2018 |
| FDA updated | 10/19/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Unavailable |
| FDA additional information | On backorder. Recovery: TBD. Check wholesalers for inventory |
| Package NDC | 55150-256-50 |
| Record 23 | Lidocaine Hydrochloride Injection |
| FDA generic name | Lidocaine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Xylocaine, Injection, 10 mg/1 mL (NDC 63323-485-57) |
| Company | Fresenius Kabi USA, LLC |
| First posted | 02/22/2012 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia, Pediatric |
| Presentation availability | Unavailable |
| FDA additional information | Next release November 2026. Check wholesalers for inventory. |
| Package NDC | 63323-485-57 |
| Record 24 | Lidocaine Hydrochloride Injection |
| FDA generic name | Lidocaine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Lidocaine Hydrochloride In Plastic Container, Injection, 200 mg/20 mL (1%; 10 mg/mL) (NDC 0409-4276-01) |
| Company | Hospira, Inc., a Pfizer Company |
| First posted | 02/22/2012 |
| FDA updated | 11/09/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia, Pediatric |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 0409-4276-01 |
| Record 25 | Lidocaine Hydrochloride Injection |
| FDA generic name | Lidocaine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-163-30) |
| Company | Eugia US LLC |
| First posted | 02/20/2018 |
| FDA updated | 10/19/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Available |
| FDA additional information | Check wholesalers for inventory |
| Package NDC | 55150-163-30 |
| Record 26 | Lidocaine Hydrochloride Injection |
| FDA generic name | Lidocaine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Lidocaine Hydrochloride And Dextrose, Injection, 8 mg/1 mL (NDC 0338-0411-02) |
| Company | Baxter Healthcare |
| First posted | 10/25/2017 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Cardiovascular |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 0338-0411-02 |
| Record 27 | Lidocaine Hydrochloride Injection |
| FDA generic name | Lidocaine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Lidocaine Hydrochloride, Injection, 300 mg/30 mL (1%; 10 mg/mL) (NDC 0409-4279-02) |
| Company | Hospira, Inc., a Pfizer Company |
| First posted | 02/22/2012 |
| FDA updated | 11/09/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia, Pediatric |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 0409-4279-02 |
| Record 28 | Lidocaine Hydrochloride Injection |
| FDA generic name | Lidocaine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Xylocaine, Injection, 20 mg/1 mL (NDC 63323-486-57) |
| Company | Fresenius Kabi USA, LLC |
| First posted | 02/22/2012 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia, Pediatric |
| Presentation availability | Unavailable |
| FDA additional information | Next release December 2026. Check wholesalers for inventory. |
| Package NDC | 63323-486-57 |
| Record 29 | Lidocaine Hydrochloride Injection |
| FDA generic name | Lidocaine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Xylocaine, Injection, 5 mg/1 mL (NDC 63323-484-57) |
| Company | Fresenius Kabi USA, LLC |
| First posted | 02/22/2012 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia, Pediatric |
| Presentation availability | Unavailable |
| FDA additional information | Estimated recovery: TBD |
| Package NDC | 63323-484-57 |
| Record 30 | Lidocaine Hydrochloride Injection |
| FDA generic name | Lidocaine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Xylocaine, Injection, 15 mg/1 mL (NDC 63323-493-91) |
| Company | Fresenius Kabi USA, LLC |
| First posted | 02/22/2012 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia, Pediatric |
| Presentation availability | Unavailable |
| FDA additional information | Estimated recovery: TBD |
| Package NDC | 63323-493-91 |
| Record 31 | Lidocaine Hydrochloride Injection |
| FDA generic name | Lidocaine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 76329-3390-1) |
| Company | Amphastar Pharmaceuticals, Inc. |
| First posted | 02/22/2012 |
| FDA updated | 11/06/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia, Pediatric |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 76329-3390-1 |
| Record 32 | Lidocaine Hydrochloride Injection |
| FDA generic name | Lidocaine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Lidocaine Hydrochloride In Plastic Container, Injection, 1,000 mg/50 mL (2%; 20 mg/mL) (NDC 0409-4277-02) |
| Company | Hospira, Inc., a Pfizer Company |
| First posted | 02/22/2012 |
| FDA updated | 11/09/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia, Pediatric |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 0409-4277-02 |
| Record 33 | Lidocaine Hydrochloride Injection |
| FDA generic name | Lidocaine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 55150-165-05) |
| Company | Eugia US LLC |
| First posted | 02/20/2018 |
| FDA updated | 10/19/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Unavailable |
| FDA additional information | On backorder. Recovery: mid-November 2026; Check wholesalers for inventory |
| Package NDC | 55150-165-05 |
| Record 34 | Lidocaine Hydrochloride Injection |
| FDA generic name | Lidocaine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Lidocaine Hydrochloride, Injection, 200 mg/20 mL (NDC 83634-651-20) |
| Company | Anthea Pharma |
| First posted | 02/22/2012 |
| FDA updated | 11/02/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia, Pediatric |
| Presentation availability | Available |
| FDA additional information | Distributed by Avenacy, LLC |
| Package NDC | 83634-651-20 |
| Record 35 | Lidocaine Hydrochloride Injection |
| FDA generic name | Lidocaine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Xylocaine, Injection, 20 mg/1 mL (NDC 63323-486-27) |
| Company | Fresenius Kabi USA, LLC |
| First posted | 02/22/2012 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia, Pediatric |
| Presentation availability | Unavailable |
| FDA additional information | Next release December 2026. Check wholesalers for inventory. |
| Package NDC | 63323-486-27 |
| Record 36 | Lidocaine Hydrochloride Injection |
| FDA generic name | Lidocaine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Xylocaine, Injection, 20 mg/1 mL (NDC 63323-495-07) |
| Company | Fresenius Kabi USA, LLC |
| First posted | 02/22/2012 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia, Pediatric |
| Presentation availability | Available |
| FDA additional information | Check wholesalers for inventory |
| Package NDC | 63323-495-07 |
| Record 37 | Lidocaine Hydrochloride Injection |
| FDA generic name | Lidocaine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Xylocaine, Injection, 20 mg/1 mL (NDC 63323-486-17) |
| Company | Fresenius Kabi USA, LLC |
| First posted | 02/22/2012 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia, Pediatric |
| Presentation availability | Unavailable |
| FDA additional information | Next release not available at this time. Check wholesalers for inventory. |
| Package NDC | 63323-486-17 |
| Record 38 | Lidocaine Hydrochloride Injection |
| FDA generic name | Lidocaine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Lidocaine Hydrochloride, Injection, 500 mg/50 mL (NDC 83634-651-50) |
| Company | Anthea Pharma |
| First posted | 02/22/2012 |
| FDA updated | 11/02/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia, Pediatric |
| Presentation availability | Available |
| FDA additional information | Distributed by Avenacy, LLC |
| Package NDC | 83634-651-50 |
| Record 39 | Lidocaine Hydrochloride Injection |
| FDA generic name | Lidocaine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Lidocaine Hydrochloride, Injection, 100 mg/5 mL (2%; 20 mg/mL) (NDC 0409-2066-05) |
| Company | Hospira, Inc., a Pfizer Company |
| First posted | 02/22/2012 |
| FDA updated | 11/09/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia, Pediatric |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 0409-2066-05 |
| Record 40 | Lidocaine Hydrochloride Injection |
| FDA generic name | Lidocaine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 65282-1605-1) |
| Company | Spectra Medical Devices, LLC |
| First posted | 06/14/2018 |
| FDA updated | 10/08/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Unavailable |
| FDA additional information | Estimated recovery: TBD |
| Package NDC | 65282-1605-1 |
| Record 41 | Lidocaine Hydrochloride Injection |
| FDA generic name | Lidocaine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 73293-0001-2) |
| Company | Huons Co., Ltd. (South Korea) |
| First posted | 07/14/2018 |
| FDA updated | 11/02/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Unavailable |
| FDA additional information | Estimated recovery: TBD |
| Package NDC | 73293-0001-2 |
| Record 42 | Lidocaine Hydrochloride Injection |
| FDA generic name | Lidocaine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Lidocaine Hydrochloride Preservative Free In Plastic Container, Injection, 100 mg/5mL (2%,20 mg/1 mL) Syringes (NDC 0409-1323-05) |
| Company | Hospira, Inc., a Pfizer Company |
| First posted | 02/22/2012 |
| FDA updated | 11/09/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia, Pediatric |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 0409-1323-05 |
| Record 43 | Lidocaine Hydrochloride Injection |
| FDA generic name | Lidocaine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Lidocaine Hydrochloride And Dextrose, Injection, 5 g/100 mL; .8 g/100 mL (NDC 0264-9598-20) |
| Company | B. Braun Medical Inc. |
| First posted | 10/25/2017 |
| FDA updated | 11/10/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Cardiovascular |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 0264-9598-20 |
| Record 44 | Lidocaine Hydrochloride Injection |
| FDA generic name | Lidocaine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Xylocaine, Injection, 20 mg/1 mL (NDC 63323-495-27) |
| Company | Fresenius Kabi USA, LLC |
| First posted | 02/22/2012 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia, Pediatric |
| Presentation availability | Available |
| FDA additional information | Check wholesalers for inventory |
| Package NDC | 63323-495-27 |
| Record 45 | Lidocaine Hydrochloride Injection |
| FDA generic name | Lidocaine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Lidocaine Hydrochloride, Injection, 10 mg/mL (NDC 55150-252-20) |
| Company | Eugia US LLC |
| First posted | 06/13/2018 |
| FDA updated | 10/19/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Unavailable |
| FDA additional information | On backorder. Recovery: late October 2026; Check wholesalers for inventory |
| Package NDC | 55150-252-20 |
| Record 46 | Lidocaine Hydrochloride Injection |
| FDA generic name | Lidocaine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 63323-202-02) |
| Company | Fresenius Kabi USA, LLC |
| First posted | 02/22/2012 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia, Pediatric |
| Presentation availability | Available |
| FDA additional information | Check wholesalers for inventory |
| Package NDC | 63323-202-02 |
| Record 47 | Lidocaine Hydrochloride Injection |
| FDA generic name | Lidocaine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Lidocaine Hydrochloride, Injection, 250 mg/50 mL (0.5%; 5 mg/mL) (NDC 0409-4278-01) |
| Company | Hospira, Inc., a Pfizer Company |
| First posted | 02/22/2012 |
| FDA updated | 11/09/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia, Pediatric |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 0409-4278-01 |
| Record 48 | Lidocaine Hydrochloride Injection |
| FDA generic name | Lidocaine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-201-10) |
| Company | Fresenius Kabi USA, LLC |
| First posted | 02/22/2012 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia, Pediatric |
| Presentation availability | Unavailable |
| FDA additional information | Next release November 2026. Check wholesalers for inventory. |
| Package NDC | 63323-201-10 |
| Record 49 | Lidocaine Hydrochloride Injection |
| FDA generic name | Lidocaine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Lidocaine Hydrochloride Preservative Free, Injection, 20 mg/2 mL (1%; 10 mg/mL) (NDC 0409-4713-32) |
| Company | Hospira, Inc., a Pfizer Company |
| First posted | 02/22/2012 |
| FDA updated | 11/09/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia, Pediatric |
| Presentation availability | Unavailable |
| FDA additional information | Next Delivery: August 2027; Estimated Recovery: September 2027; Shortage per Manufacturer: Manufacturing Delay |
| Package NDC | 0409-4713-32 |
| Record 50 | Lidocaine Hydrochloride Injection |
| FDA generic name | Lidocaine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Lidocaine Hydrochloride, Preservative Free, Injection, 20 mg/1 mL (NDC 0143-9594-25) |
| Company | Hikma Pharmaceuticals USA, Inc. |
| First posted | 06/13/2018 |
| FDA updated | 10/14/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Available |
| FDA additional information | Additional lots are scheduled to be manufactured. Product will be made available as it is released. |
| Package NDC | 0143-9594-25 |
| Record 51 | Lidocaine Hydrochloride Injection |
| FDA generic name | Lidocaine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Lidocaine Hydrochloride, Preservative Free, Injection, 10 mg/1 mL (NDC 0143-9595-25) |
| Company | Hikma Pharmaceuticals USA, Inc. |
| First posted | 06/13/2018 |
| FDA updated | 10/14/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Unavailable |
| FDA additional information | Product temporarily on backorder. Additional lots will be available in the November 2026 timeframe. |
| Package NDC | 0143-9595-25 |
| Record 52 | Lidocaine Hydrochloride Injection |
| FDA generic name | Lidocaine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Xylocaine, Injection, 15 mg/1 mL (NDC 63323-493-97) |
| Company | Fresenius Kabi USA, LLC |
| First posted | 02/22/2012 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia, Pediatric |
| Presentation availability | Unavailable |
| FDA additional information | Estimated recovery: TBD |
| Package NDC | 63323-493-97 |
| Record 53 | Lidocaine Hydrochloride Injection |
| FDA generic name | Lidocaine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Lidocaine Hydrochloride In Plastic Container, Injection, 400 mg/20 mL (2%; 20 mg/mL) (NDC 0409-4277-01) |
| Company | Hospira, Inc., a Pfizer Company |
| First posted | 02/22/2012 |
| FDA updated | 11/09/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia, Pediatric |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 0409-4277-01 |
| Record 54 | Lidocaine Hydrochloride Injection |
| FDA generic name | Lidocaine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-162-05) |
| Company | Eugia US LLC |
| First posted | 02/20/2018 |
| FDA updated | 10/19/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Available |
| FDA additional information | Check wholesalers for inventory |
| Package NDC | 55150-162-05 |
| Record 55 | Lidocaine Hydrochloride Injection |
| FDA generic name | Lidocaine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Lidocaine Hydrochloride, Injection, 300 mg/30 mL (NDC 83634-653-30) |
| Company | Anthea Pharma |
| First posted | 02/22/2012 |
| FDA updated | 11/02/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia, Pediatric |
| Presentation availability | Available |
| FDA additional information | Distributed by Avenacy, LLC |
| Package NDC | 83634-653-30 |
| Record 56 | Lidocaine Hydrochloride Injection |
| FDA generic name | Lidocaine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-27) |
| Company | Fresenius Kabi USA, LLC |
| First posted | 02/22/2012 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia, Pediatric |
| Presentation availability | Available |
| FDA additional information | Check wholesalers for inventory |
| Package NDC | 63323-492-27 |
| Record 57 | Lidocaine Hydrochloride Injection |
| FDA generic name | Lidocaine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Lidocaine Hydrochloride Preservative Free, Injection, 300 mg/20 mL (1.5%; 15 mg/mL) (NDC 0409-4776-01) |
| Company | Hospira, Inc., a Pfizer Company |
| First posted | 02/22/2012 |
| FDA updated | 11/09/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia, Pediatric |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 0409-4776-01 |
| Record 58 | Lidocaine Hydrochloride Injection |
| FDA generic name | Lidocaine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Lidocaine Hydrochloride Preservative Free, Injection, 20 mg/1 mL (NDC 63323-208-05) |
| Company | Fresenius Kabi USA, LLC |
| First posted | 02/22/2012 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia, Pediatric |
| Presentation availability | Unavailable |
| FDA additional information | Next release December 2026. Check wholesalers for inventory. |
| Package NDC | 63323-208-05 |
| Record 59 | Lidocaine Hydrochloride Injection |
| FDA generic name | Lidocaine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Xylocaine, Injection, 5 mg/1 mL (NDC 63323-491-57) |
| Company | Fresenius Kabi USA, LLC |
| First posted | 02/22/2012 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia, Pediatric |
| Presentation availability | Available |
| FDA additional information | Check wholesalers for inventory |
| Package NDC | 63323-491-57 |
| Record 60 | Lidocaine Hydrochloride Injection |
| FDA generic name | Lidocaine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Lidocaine Hydrochloride Preservative Free, Injection, 50 mg/5 mL (1%; 10 mg/mL) (NDC 0409-4713-02) |
| Company | Hospira, Inc., a Pfizer Company |
| First posted | 02/22/2012 |
| FDA updated | 11/09/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia, Pediatric |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 0409-4713-02 |
| Record 61 | Lidocaine Hydrochloride Injection |
| FDA generic name | Lidocaine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Lidocaine Hydrochloride In Plastic Container, Injection, 10 mg/1 mL (NDC 63323-201-02) |
| Company | Fresenius Kabi USA, LLC |
| First posted | 02/22/2012 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia, Pediatric |
| Presentation availability | Available |
| FDA additional information | Check wholesalers for inventory |
| Package NDC | 63323-201-02 |
| Record 62 | Lidocaine Hydrochloride Injection |
| FDA generic name | Lidocaine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Lidocaine Hydrochloride In Plastic Container, Injection, 500 mg/50 mL (1%; 10 mg/mL) (NDC 0409-4276-02) |
| Company | Hospira, Inc., a Pfizer Company |
| First posted | 02/22/2012 |
| FDA updated | 11/09/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia, Pediatric |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 0409-4276-02 |
| Record 63 | Lidocaine Hydrochloride Injection |
| FDA generic name | Lidocaine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Lidocaine Hydrochloride, Injection, 100 mg/10 mL (NDC 83634-651-10) |
| Company | Anthea Pharma |
| First posted | 02/22/2012 |
| FDA updated | 11/02/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia, Pediatric |
| Presentation availability | Available |
| FDA additional information | Distributed by Avenacy, LLC |
| Package NDC | 83634-651-10 |
| Record 64 | Lidocaine Hydrochloride Injection |
| FDA generic name | Lidocaine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Lidocaine Hydrochloride And Dextrose, Injection, 5 g/100 mL; .4 g/100 mL (NDC 0264-9594-10) |
| Company | B. Braun Medical Inc. |
| First posted | 10/25/2017 |
| FDA updated | 11/10/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Cardiovascular |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 0264-9594-10 |
| Record 65 | Lidocaine Hydrochloride Injection |
| FDA generic name | Lidocaine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Lidocaine Hydrochloride, Injection, 200 mg/10 mL (2%; 20 mg/mL) (NDC 0409-4282-02) |
| Company | Hospira, Inc., a Pfizer Company |
| First posted | 02/22/2012 |
| FDA updated | 11/09/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia, Pediatric |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 0409-4282-02 |
Lidocaine: practical discussion
For local and regional blocks in dogs and cats, lidocaine has a fast onset (10 to 15 minutes) and an intermediate duration of action (60 to 120 minutes), and is used for short diagnostic and surgical procedures. Bupivacaine has a slow onset (20 to 30 minutes) and a long duration of action (240 to 360 minutes), and is used to control pain before and after surgery. Local anesthetic doses, especially for cats and small dogs, should be calculated carefully.
CDER Shortage Status and Presentation Details
FDA lists human-labeled lidocaine hydrochloride injection in shortage on the Center for Drug Evaluation and Research database. Availability status varies by individual package NDC and manufacturer, with specific product presentations designated as Available, Limited Availability, or Unavailable.
FDA lists human-labeled lidocaine in shortage as of 2026-11-08.
Reading FDA lidocaine records
When reviewing FDA shortage data, two NDCs from the same manufacturer and strength may have different availability statuses.
Vetinuity
Vetinuity supports treatment options with citations and dose math.
● SOURCES
- 1. FDA CDER human drug shortage records. FDA shortage data. Checked 2026-11-13.
- 2. FDA CVM current and resolved animal drug shortages. FDA shortage data. Checked 2026-11-13.
- 3. FDA CVM shortage information. FDA shortage data. Checked 2026-11-13.
- 4. Local and regional anesthesia. PMID 10932828. Abstract. Checked 2026-11-08.
● RELATED ANSWERS
- Clindamycin FDA Drug Shortage Status for Veterinarians
FDA shortage status details for clindamycin injection, including manufacturer availability and supply dates.
- Dextrose Drug Shortage Status and Supply
FDA lists human-labeled dextrose injection in shortage, with various concentrations showing available, limited, or unavailable supply.
- Dexmedetomidine Shortage Status and Veterinary Supply
FDA lists human-labeled dexmedetomidine injection in shortage, while Dexdomitor provides 0.1 mg/mL and 0.5 mg/mL veterinary formulations.
- Veterinary drugs FDA drug shortage status and records
Track veterinary and human drug shortages using FDA Center for Veterinary Medicine tables and CDER records.
● FAQ
Are estimated recovery dates in FDA lidocaine shortage records guaranteed?
FDA lists estimated recovery dates for lidocaine, not guaranteed return dates. One saved record (Fresenius Kabi USA, LLC, 63323-496-97) states: Estimated recovery: TBD
Is lidocaine listed on the FDA CVM animal drug shortage table?
As of 2026-11-08, lidocaine is absent from the FDA CVM animal drug shortage table. This does not establish product availability.
● OPEN APP
SEE HOW VETINUITY HANDLES THIS.
Vetinuity explains clinical options with journal citations.
The veterinarian diagnoses and prescribes.